According to Nectar Lifesciences 's latest financial reports the company's current EPS (TTM) is -$0.01430. In 2022 the company made an earnings per share (EPS) of -$0.008347 an increase over its 2021 EPS that were of -$0.01699.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.01430 | 71.36% |
2022 | -$0.008347 | -50.86% |
2021 | -$0.01699 | 13.83% |
2020 | -$0.01492 | -155.61% |
2019 | $0.02683 |